Amidst a tumultuous year for global health, there are rays of hope and remarkable achievements that deserve our attention. Let's dive into some of the shining moments that offer a glimmer of light in an otherwise challenging year.
A Year of Resilience and Progress in Global Health
The year 2025 has been a rollercoaster for global health initiatives, with the dissolution of USAID and significant aid cuts leaving many programs in jeopardy. Yet, amidst this turmoil, there are stories of resilience and remarkable progress that deserve our recognition.
The Impact of Aid Cuts: A Controversial Move
The decision to dissolve USAID and reduce global health funding has sparked intense debate. While some argue that it's a necessary step towards self-sustaining healthcare systems, others point to the devastating consequences, with estimates suggesting over 700,000 lives lost as a result. Dr. Atul Gawande, a former USAID global health head, describes it as a "brutal year" and a "setback of staggering proportions." But here's where it gets controversial: the State Department defends these moves, claiming they're implementing a groundbreaking global health strategy. Who do you think is right? Share your thoughts in the comments!
A Triple Crown for Global Health
In a year marked by challenges, there were also moments of triumph. The Maldives achieved a remarkable feat by becoming the first country to eliminate mother-to-child transmission of HIV, syphilis, and hepatitis B. This historic milestone provides hope and inspiration for countries worldwide, as they strive towards the same goal. WHO Director General Tedros Adhanom Ghebreyesus praised the achievement, highlighting the unwavering commitment towards universal health coverage, including migrants, as a key factor.
Breaking Records: HIV and Malaria Elimination
Brazil, the largest country in the Americas, joined the fight against HIV transmission between mothers and children. This achievement is a testament to the progress made in the last 25 years, with Anurita Bains, UNICEF associate director for HIV/AIDS, describing it as one of the greatest public health achievements in recent history. Additionally, Suriname, Timor-Leste, and Georgia were certified as malaria-free by WHO in 2025. Suriname, in particular, deserves a special mention as the first country in the Amazon region to eliminate malaria, despite its mosquito-friendly forests. These certifications are a result of the tireless work of community health workers, who played a crucial role in diagnosing and treating foreign workers in Suriname's gold mining areas.
The Fight Against Malaria: A New Weapon
While malaria still poses a significant threat, with over 82 million cases and 610,000 deaths in 2024, there's a glimmer of hope with the introduction of a new malaria vaccine. Seven countries, including Burundi, Ethiopia, and Zambia, introduced the recently approved vaccine in 2025, bringing the total to 24, according to WHO. This new weapon in the arsenal offers encouragement and a potential turning point in the fight against malaria.
Advancements in HIV Prevention: A Nearly Bulletproof Drug
Lenacapavir, an injectable drug administered twice a year to prevent HIV, was approved in the U.S. and recommended by WHO in 2025. Clinical trials showed 100% effectiveness in preventing HIV in women and 96% in men, without the stigma associated with daily pills. In a partnership between the U.S. Department of State and the Global Fund, the first shipments of lenacapavir were delivered to Eswatini and Zambia, providing a total of 4 million doses for 2 million people in low- and middle-income countries. Anurita Bains of UNICEF calls lenacapavir a "game-changer" and a transformative step, especially for women who may face challenges in disclosing their medication intake.
A Step Towards Health Equity: Generic Manufacturing of Lenacapavir
In a significant milestone for global health equity, the U.S. manufacturer Gilead Sciences announced that it will allow generic manufacturing of lenacapavir in low- and middle-income countries. This move, funded by philanthropies including the Gates Foundation and the Clinton Health Initiative, is expected to debut in 2027. The Global Fund to fight AIDS, Tuberculosis, and Malaria praised this development, stating that it marks the first time an HIV prevention product will be introduced simultaneously in high-income and low- and middle-income countries.
Reducing Lead Exposure in Bangladesh: A Success Story
A government survey published in 2025 found a likely decline in blood lead levels in children in Bangladesh, with a definite 10-percentage-point decline among children in the capital Dhaka region. Lead exposure, often from paints, batteries, and dyes like lead chromate, affects one in three children in the country, leading to developmental delays, neurologic deficits, and kidney and cardiovascular problems later in life. The Bangladeshi government's education efforts, such as warnings about sprinkling lead-based dyes on spices, have played a crucial role in reducing lead exposure. While funding from USAID has fallen, new initiatives announced by Bloomberg Philanthropies in 2025 offer hope for continued progress in lead prevention projects in Asia, Africa, and South America.
A More Accessible HPV Vaccine Protocol
The human papillomavirus (HPV) vaccine, first approved in 2006, has been hailed as an effective way to prevent cervical cancer in girls. However, the original three-dose regimen presented financial and logistical challenges for lower-resource countries and parents. In 2025, a new strategy gained acceptance, with years of testing confirming that one dose is highly effective for younger girls, and older girls can benefit from two doses. This more accessible protocol was endorsed by 11 countries, including Angola, Benin, and Pakistan, while Belarus, Oman, and China adopted the two-dose strategy. Dr. Atul Gawande, formerly of USAID, emphasizes the impact of HPV vaccination, stating that for every 70 girls vaccinated in low-income countries, one life is saved from cervical cancer. This extraordinary impact has reached 86 million girls and has the potential for further advancement.
A Six-in-One Vaccine: Protecting Against Multiple Diseases
In a significant development, a hexavalent vaccine, covering six diseases, was launched in low-income countries for the first time in July 2025. Mauritania and Senegal, which previously used a five-in-one vaccine and separate vaccines for polio, now have access to this comprehensive vaccine. The addition of polio protection reduces the number of shots required, making it more accessible for children and parents. GAVI, the Vaccine Alliance, notes that adding one new virus to the vaccine's count can make a significant difference in protecting children's health.
Pandemic Preparedness: A Genomic Data Platform for Africa
In November 2025, the Africa Centres for Disease Control and Prevention launched Africa Genome Archiving for Response and Insight (AGARI), an online platform that allows researchers across the continent to share genetic data on disease-causing pathogens. By quickly identifying, characterizing, and responding to infectious disease outbreaks, Africa can increase its ability to minimize damage and disruption in future global pandemics. Dr. Amesh Adalja, a senior scholar at the Center for Health Security at Johns Hopkins, emphasizes the importance of Africa's genomic expertise and capacity in strengthening outbreak response.
As we reflect on the year 2025, it's evident that despite the challenges, there were remarkable achievements in global health. From eliminating mother-to-child transmission of HIV and hepatitis B to the introduction of new vaccines and accessible protocols, these successes offer hope and inspiration. While the road ahead may be uncertain, especially with the changes in U.S. health aid abroad, the progress made in 2025 serves as a reminder of the resilience and dedication of global health initiatives. What do you think are the most significant achievements in global health this year? Share your thoughts and let's continue the conversation!
